A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2002
10/22/2002	US6468219 Implantable telemetric transcranial doppler device
10/22/2002	CA2406976A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2118670C Pharmaceutical compositions in semisolid form and a device for administration thereof
10/22/2002	CA2106954C Dry starch-iodine pharmaceutical formulations
10/17/2002	WO2002082462A2 Stabilization and terminal sterilization of phospholipid formulations
10/17/2002	WO2002081649A2 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
10/17/2002	WO2002081619A1 Glycosaminoglycan/collagen complexes and use thereof
10/17/2002	WO2002081536A1 Film-forming composition for topical use and use thereof for delivering active agents
10/17/2002	WO2002081524A1 Method for producing low-viscous, aqueous cellulose ether solutions
10/17/2002	WO2002081507A2 Interferon gamma polypeptide variants
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081027A1 An antioxidant composition and a cosmetic or pharmaceutical composition
10/17/2002	WO2002080987A1 Anti-cd19 immunotoxins
10/17/2002	WO2002080981A2 Polynucleotide binding complexes comprising sterols and saponins
10/17/2002	WO2002080980A1 Lectin-directed prodrug delivery system
10/17/2002	WO2002080979A2 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	WO2002080978A2 Pharmaceutical compositions comprising ascomycin
10/17/2002	WO2002080977A1 Biodegradable carrier and method for preparation thereof
10/17/2002	WO2002080976A2 Hsa-free formulations of interferon-beta
10/17/2002	WO2002080964A1 Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
10/17/2002	WO2002080941A1 Compositions for preparing external carbon dioxide agents
10/17/2002	WO2002080931A1 New use of glyconjugates of glucocorticosteroids as a targeting to the colon
10/17/2002	WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/17/2002	WO2002080910A1 Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
10/17/2002	WO2002080902A1 Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono- m toluidide and pvp
10/17/2002	WO2002080901A2 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates
10/17/2002	WO2002080887A2 Timed pulse release composition
10/17/2002	WO2002080884A2 Powder inhaler formulations
10/17/2002	WO2002080883A2 Method and composition for solubilising a biologically active compound with low water solubility
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080850A2 Bulking agents as satiety agents
10/17/2002	WO2002080840A2 Immunity adjuvant containing a complexed metal cation and vaccine containing same
10/17/2002	WO2002080797A1 Vessel sealing instrument
10/17/2002	WO2002080754A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions
10/17/2002	WO2002080681A1 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/17/2002	WO2002080678A1 Antifungal composition with enhanced bioavailability
10/17/2002	WO2002080648A2 Mucosal boosting following parenteral priming
10/17/2002	WO2002062260A3 Improved ophthalmic and contact lens solutions containing forms of vitamin b
10/17/2002	WO2002043699A3 Preparation of large liposomes by infusion into peg
10/17/2002	WO2002043567A3 A method of treating cancer
10/17/2002	WO2002036145A3 Kahalalide f formulation
10/17/2002	WO2002007772A3 Improved oral dosage formulations
10/17/2002	WO2001058238A9 Method and system for producing customized cosmetic and pharmaceutical formulations on demand
10/17/2002	US20020151792 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
10/17/2002	US20020151710 Fusion protein delivery system and uses thereof
10/17/2002	US20020151689 Method of killing target cells in harvested cell populations with one or more immuno-toxins
10/17/2002	US20020151686 Polypeptide for use in the treatment and prevention of infections
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151650 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/17/2002	US20020151646 Comprises glutamic acid, sodium glutamate, or glycine; for measurement of coagulation factor; sensitivity; blood screening; freeze-drying
10/17/2002	US20020151599 Formulations having an antiviral action
10/17/2002	US20020151598 Bronchodilating compositions and methods
10/17/2002	US20020151597 Formoterol, or a derivative; long term storage stability
10/17/2002	US20020151593 Water-soluble creatine monohydrate formulations and process for their preparation
10/17/2002	US20020151589 Levodopa (l-dopa) ethyl ester, carbidopa or benserazide, a filler, a disintegrant, and a lubricant tablets used to treat Parkinson's disease
10/17/2002	US20020151536 Substituted azetidinone is used as sterol absorption inhibitor and a fibric acid derivative selected from fenofibrate, clofibrate, gemfibrozil, ciprofibrate, bezafibrate, clinofibrate etc
10/17/2002	US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002	US20020151526 Bile-acid conjugates useful for sustained release of L-DOPA, inhibitors of catechol O-methyl transferase and/or inhibitors of L-aromatic amino acid decarboxylase
10/17/2002	US20020151525 Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation
10/17/2002	US20020151523 Linear cyclodextrin copolymers
10/17/2002	US20020151508 Administering therapeutically effective amount of liposomal anthracycline composition in association with therapeutically effective amount of antibody directed against extracellular domain of growth factor receptor
10/17/2002	US20020151493 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151088 Rapamycin conjugates
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151060 Generating transfection liquids; obtain nutrient broths, incubate with nucleic acids, monitor ionic mobility, store
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150972 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/17/2002	US20020150670 Heparin compositions and methods of making and using the same
10/17/2002	US20020150638 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/17/2002	US20020150629 Enhancing absorption; mixture of zinc compound and dipeptide
10/17/2002	US20020150628 Microbiocides; viricides; anticancer agents
10/17/2002	US20020150625 Fineness particle size; hormone replacement therapy
10/17/2002	US20020150624 Mixture of drug, aminoacrylate polymer and acid
10/17/2002	US20020150622 Controlled release of anti-arrhythmic agents
10/17/2002	US20020150620 Oral itraconazole formulations and methods of making the same
10/17/2002	US20020150616 Mixture of drug with acid and polymer
10/17/2002	US20020150605 Drug supported by biodegradable polymer such as crosslinked hyaluronic acid
10/17/2002	US20020150603 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
10/17/2002	US20020150602 Thickener oil phase
10/17/2002	US20020150600 Conjugate, its preparation and use
10/17/2002	US20020150596 Ointment having micro bubbles containing a liquid and methods
10/17/2002	US20020150585 Intensify immunology response; polysaccharide complex
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150550 Cosmetic surgery
10/17/2002	US20020150549 Sustained release
10/17/2002	US20020150548 Isolatable, water soluble, and hydrolytically stable active sulfones of poly (ethylene glycol) and related polymers for modification of surfaces and molecules
10/17/2002	US20020150544 Water soluble film for oral administration with instant wettability
10/17/2002	US20020150539 Ultrasound imaging and treatment
10/17/2002	DE10118109A1 Production of glycerol carbamate esters useful as thickeners in detergent, cosmetic and pharmaceutical compositions, comprises reacting a glycerol, diglycerol or polyglycerol carbonate with an amine
10/17/2002	DE10117728A1 Pharmazeutische Formulierungen für Xanthogenate Pharmaceutical formulations for xanthates
10/17/2002	DE10117049A1 New pharmaceutical composition useful for preparing solid and liquid dosage forms, e.g. ophthalmic solutions, comprises an anionic surfactant with a basic polymer or a cationic surfactant with acidic polymer, and an active ingredient
10/17/2002	CA2762966A1 Hsa-free formulations of interferon-beta
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443694A1 Anti-cd19 immunotoxins
10/17/2002	CA2443362A1 Stabilization and terminal sterilization of phospholipid formulations

1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1712